Beta Drugs Technical Analysis

Beta Drugs Ltd Technical Analysis

Beta Drugs Ltd technical analysis is gaining attention among traders and investors tracking Beta Drugs Ltd Technical Analysis trends in the Indian stock market. Beta Drugs Ltd (NSE: BETA, BSE: 535022) is currently trading at ₹1394.40, showing a -1.59% move as of Tue, Apr 21, 2026.

This detailed Beta Drugs Ltd technical analysis covers support & resistance levels, moving averages, indicators, and overall market sentiment to help investors make informed decisions.

Beta Drugs Ltd Stock Overview

Beta Drugs Ltd operates in the Health technology sector under the Pharmaceuticals: major industry. With a market capitalization of ₹14.08B and a PE ratio of 33.59, Beta Drugs Ltd remains a key stock to watch in Beta Drugs Ltd Technical Analysis searches.

Key Metrics

• Market Cap: ₹14.08B
• PE Ratio: 33.59
• Dividend Yield: 0
• Sector: Health technology
• Industry: Pharmaceuticals: major

These fundamentals play an important role in Beta Drugs Ltd technical analysis and valuation tracking.

Beta Drugs Ltd Support and Resistance Levels

Classic Pivot Levels

In Beta Drugs Ltd technical analysis, pivot levels help identify potential reversal and breakout zones.

• Resistance 3: 1617.03
• Resistance 2: 1381.43
• Resistance 1: 1285.37
• Pivot Point: 1145.83
• Support 1: 1049.77
• Support 2: 910.23
• Support 3: 674.63

Conditional Insight

Beta Drugs Ltd technical analysis suggests a bearish to neutral trend as the price is below the pivot point. Immediate support is seen near 1049.77 and 910.23.

Fibonacci Levels Analysis

Fibonacci levels are widely used in Beta Drugs Ltd technical analysis to identify retracement zones.

• Fibonacci R3: 1381.43
• Fibonacci R2: 1291.43
• Fibonacci R1: 1235.83
• Fibonacci Pivot: 1145.83
• Fibonacci S1: 1055.83
• Fibonacci S2: 1000.23
• Fibonacci S3: 910.23

Beta Drugs Ltd technical analysis indicates consolidation between Fibonacci pivot and resistance zones.

Beta Drugs Ltd Moving Average Analysis

Moving averages are key indicators in Beta Drugs Ltd technical analysis for identifying trend direction.

• 10 EMA: 1357.63
• 20 EMA: 1319.07
• 30 EMA: 1295.80
• 50 EMA: 1301.19
• 100 EMA: 1387.49
• 200 EMA: 1508.04

Trend Logic

Beta Drugs Ltd technical analysis indicates bearish pressure, with price trading below key moving averages.

Long-term trend in Beta Drugs Ltd technical analysis remains positive above 200 EMA.

Beta Drugs Ltd Technical Indicators Overview

Momentum Indicators

• RSI: 51.71
• MACD: 49.01
• Signal: 53.60
• ADX: 31.25
• Momentum: -232.50

RSI Logic

Beta Drugs Ltd technical analysis shows RSI in neutral range, suggesting consolidation.

MACD Logic

Beta Drugs Ltd technical analysis indicates bearish momentum with MACD below signal line.

Beta Drugs Ltd Overall Recommendation

• Overall Recommendation Score: -0.16
• Moving Average Recommendation: -0.13
• Other Indicators Recommendation: -0.18

Overall Beta Drugs Ltd technical analysis sentiment remains neutral with mixed signals.

Beta Drugs Ltd Technical Analysis Conclusion

Beta Drugs Ltd technical analysis suggests that traders should closely monitor price action around ₹1394.40 and key pivot level 1145.83. Breakouts above resistance or breakdown below support will define the next trend in Beta Drugs Ltd technical analysis.

Investors searching for Beta Drugs Ltd Technical Analysis should track moving averages, RSI levels, and volume trends to identify potential entry and exit opportunities. As market conditions change, Beta Drugs Ltd technical analysis will continue to play a crucial role in short-term trading and long-term investment strategies.